Never miss a great news story!
Get instant notifications from Economic Times
AllowNot now


You can switch off notifications anytime using browser settings.

News

11,588.35-73.5
Stock Analysis, IPO, Mutual Funds, Bonds & More

Sun Pharma falls 7.4% on fresh FDA alert

The fresh warning letter to the company comes after the facility was first inspected by the US drug regulator in September 2014.

, ET Bureau|
Updated: Dec 22, 2015, 03.13 AM IST
0Comments
The fresh warning letter to the company comes after the facility was first inspected by the US drug regulator in September 2014.
The fresh warning letter to the company comes after the facility was first inspected by the US drug regulator in September 2014.
Sun Pharma fell 7.4 per cent after the company got a warning letter from the US Food and Drug Administration (FDA) for its facility located at Halol, Gujarat. The fresh warning letter to the company comes after the facility was first inspected by the US drug regulator in September 2014. In a release issued to BSE, Sun Pharma said: "Post the September 2014 inspection, the USFDA has withheld future product approvals from the Halol facility. This situation may continue until all issues are resolved. Sun Pharma expects to request a re-inspection by USFDA upon completion of its remediation commitments." In intra-day trade, the stock touched a low of Rs 732, before recovering to end at Rs 755.

Sun Pharma falls 7.4% on fresh FDA alert

Comments
Add Your Comments
Commenting feature is disabled in your country/region.
Download The Economic Times Business News App for the Latest News in Business, Sensex, Stock Market Updates & More.

Other useful Links


Follow us on


Download et app


Copyright © 2019 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service